Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ABATTIS BIOCEUTIC (CNSX: FLU)
0.0950 CAD  UNCHANGED
Streaming Delayed Price  /  Updated: 10:32 AM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 0.0650 (0)
Ask (Size) 0.1400 (0)
Prev. Close 0.0950
Today's Range 0.0950 - 0.0950
52wk Range 0.0500 - 0.3000
Shares Outstanding 26,589,927
Dividend Yield N/A
Top News
More News
CVS Earnings Rise on Cold, Flu Season Sales
May 01, 2013
DailyFinance.com : Eliot J. Schechter/Bloomberg via Getty Images NEW YORK -- CVS posted a higher first-quarter profit on Wednesday as a more severe cold and flu season boosted sales and more new,... Read More
category earnings , retail , flu , and 4 more.
from DailyFinance.com
Shareholder Update - Year in Review
March 13, 2013
from ACCESSWIRE

More News
Read More
SHAREHOLDER UPDATE – YEAR IN REVIEW
March 13, 2013
category CONTRACTS , ACQUISITIONS , Company Announcement , and 31 more.
from Latest eTeligis Press Releases with 'Plus' ranking
Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project
March 12, 2013
category Company Announcement , ADVISORY
from Latest eTeligis Press Releases with 'Plus' ranking
Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project
March 12, 2013
from PR Newswire
Abattis Terminates $600,000 Private Placement
March 11, 2013
from PR Newswire
Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance
March 08, 2013
category PHARMACEUTICALS , BIOTECHNOLOGY , Company Announcement , and 1 more.
from Latest eTeligis Press Releases with 'Plus' ranking
Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance
March 08, 2013
from PR Newswire
Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea
March 06, 2013
category Company Announcement , ADVISORY
from Latest eTeligis Press Releases with 'Plus' ranking
Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea
March 06, 2013
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here